- Home
- ORC vs AUTL Comparison
ORC vs AUTL Comparison
Compare ORC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORC | AUTL |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 368.6M |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ORC | AUTL |
|---|---|---|
| Price | $7.41 | $1.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $7.50 | ★ $8.33 |
| AVG Volume (30 Days) | ★ 5.8M | 3.9M |
| Earning Date | 01-29-2026 | 11-12-2025 |
| Dividend Yield | ★ 19.51% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $80,187,000.00 | $51,128,000.00 |
| Revenue This Year | $82.99 | $658.11 |
| Revenue Next Year | $61.79 | $91.34 |
| P/E Ratio | $12.86 | ★ N/A |
| Revenue Growth | 5.93 | ★ 406.67 |
| 52 Week Low | $5.69 | $1.11 |
| 52 Week High | $9.01 | $2.80 |
Technical Indicators
Market Signals| Indicator | ORC | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 58.78 | 60.25 |
| Support Level | $7.09 | $1.56 |
| Resistance Level | $7.44 | $1.69 |
| Average True Range (ATR) | 0.12 | 0.09 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 67.19 | 89.92 |
Price Performance
Historical ComparisonAbout ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.